Placebo-controlled studies in rheumatoid arthritis: ethical issues
- 1 January 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 353 (9150), 400-403
- https://doi.org/10.1016/s0140-6736(98)01373-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 1997
- Mortality in the rheumatic diseasesArthritis & Rheumatism, 1995
- Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. results of a 48‐week multicenter study comparing low‐dose cyclosporine with placeboArthritis & Rheumatism, 1994
- THE OPTIMAL MANAGEMENT OF EARLY RHEUMATOID DISEASE: THE KEY TO PREVENTING DISABILITYRheumatology, 1994
- SCIENTIFIC AND ETHICAL ISSUES IN THE USE OF PLACEBO CONTROLS IN CLINICAL TRIALSAnnual Review of Public Health, 1994
- Sulfasalazine in early rheumatoid arthritis. A 48‐week double‐blind, prospective, placebo‐controlled studyArthritis & Rheumatism, 1993
- Informed consent: study of quality of information given to participants in a clinical trial.BMJ, 1991
- The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis results of two metaanalysesArthritis & Rheumatism, 1990
- The Ethics of Placebo Treatment in Rheumatoid Arthritis Drug TrialsRheumatology, 1989
- Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?New England Journal of Medicine, 1983